Zabaglo L - Search Results

1

Factors predicting late recurrence for estrogen receptor-positive breast cancer.

Sestak I, Dowsett M, Zabaglo L, Lopez-Knowles E, Ferree S, Cowens JW, Cuzick J. Sestak I, et al. Among authors: zabaglo l. J Natl Cancer Inst. 2013 Oct 2;105(19):1504-11. doi: 10.1093/jnci/djt244. Epub 2013 Sep 12. J Natl Cancer Inst. 2013. PMID: 24029245 Free PMC article.

2

Measurement of markers for breast cancer in a model system using laser scanning cytometry.

Zabaglo L, Ormerod MG, Dowsett M. Zabaglo L, et al. Cytometry. 2000 Nov 1;41(3):166-71. doi: 10.1002/1097-0320(20001101)41:3<166::aid-cyto2>3.0.co;2-y. Cytometry. 2000. PMID: 11042612 Free article.

3

Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.

Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M. Zabaglo L, et al. Cytometry A. 2003 Oct;55(2):102-8. doi: 10.1002/cyto.a.10071. Cytometry A. 2003. PMID: 14505315 Free article.

4

Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry.

Zabaglo L, Ormerod MG, Dowsett M. Zabaglo L, et al. Cytometry B Clin Cytom. 2003 Nov;56(1):55-61. doi: 10.1002/cyto.b.10055. Cytometry B Clin Cytom. 2003. PMID: 14582137 Free article.

5

Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques.

Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M. Ring AE, et al. Among authors: zabaglo l. Br J Cancer. 2005 Mar 14;92(5):906-12. doi: 10.1038/sj.bjc.6602418. Br J Cancer. 2005. PMID: 15714202 Free PMC article.

6

Who would have thought a single Ki67 measurement would predict long-term outcome?

Dowsett M, A'Hern R, Salter J, Zabaglo L, Smith IE. Dowsett M, et al. Among authors: zabaglo l. Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S15. doi: 10.1186/bcr2434. Epub 2009 Dec 18. Breast Cancer Res. 2009. PMID: 20030866 Free PMC article. No abstract available.

7

Comparative validation of the SP6 antibody to Ki67 in breast cancer.

Zabaglo L, Salter J, Anderson H, Quinn E, Hills M, Detre S, A'Hern R, Dowsett M. Zabaglo L, et al. J Clin Pathol. 2010 Sep;63(9):800-4. doi: 10.1136/jcp.2010.077578. Epub 2010 Jul 29. J Clin Pathol. 2010. PMID: 20671052

8

Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer.

Anderson H, Hills M, Zabaglo L, A'hern R, Leary AF, Haynes BP, Smith IE, Dowsett M. Anderson H, et al. Among authors: zabaglo l. Ann Oncol. 2011 Aug;22(8):1770-6. doi: 10.1093/annonc/mdq700. Epub 2011 Feb 1. Ann Oncol. 2011. PMID: 21285137 Free article.

9

Predictive algorithms for adjuvant therapy: TransATAC.

Dowsett M, Salter J, Zabaglo L, Mallon E, Howell A, Buzdar AU, Forbes J, Pineda S, Cuzick J. Dowsett M, et al. Among authors: zabaglo l. Steroids. 2011 Jul;76(8):777-80. doi: 10.1016/j.steroids.2011.02.032. Epub 2011 Apr 4. Steroids. 2011. PMID: 21470560

10

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF. Cuzick J, et al. Among authors: zabaglo l. J Clin Oncol. 2011 Nov 10;29(32):4273-8. doi: 10.1200/JCO.2010.31.2835. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters